Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery
Following recent regulatory approvals of two chimeric antigen receptor T-cell (CAR-T) therapies, the field now faces a number of post-approval challenges. These challenges are in some respects defined and, in others, uncertain due to the nascence of the field. At present, information pertaining to s...
Main Authors: | Lam, C, Meinert, E, Halioua-Haubold, C, Carter, A, Yang, A, Brindley, D, Cui, Z |
---|---|
Format: | Journal article |
Published: |
BMJ Journals
2019
|
Similar Items
-
Tackling the unique challenges of capacity planning for autologous cell therapies
by: Lam, C, et al.
Published: (2020) -
Comparison between centralised and decentralised supply chain of autologous CAR-T therapies: a UK case study based on discrete event simulation
by: Lam, C, et al.
Published: (2021) -
Digital technology in somatic and gene therapy trials of pediatric patients with ocular diseases: protocol for a scoping review
by: Meinert, E, et al.
Published: (2019) -
Impact of fast-track regulatory designations on strategic commercialization decisions for autologous cell therapies
by: Lam, C, et al.
Published: (2022) -
A multistep research protocol to develop and implement validated guidelines for CMO RFI and RFP processes: biopharmaceutical vendor evaluation and selection minimum standards (BioVesel)
by: Brindley, D, et al.
Published: (2018)